PortfoliosLab logoPortfoliosLab logo
SNDX vs. CIFR
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SNDX vs. CIFR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Syndax Pharmaceuticals, Inc. (SNDX) and Cipher Mining Inc. (CIFR). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SNDX vs. CIFR - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SNDX
Syndax Pharmaceuticals, Inc.
11.19%58.93%-38.82%-15.09%16.26%26.90%
CIFR
Cipher Mining Inc.
-12.80%218.10%12.35%637.50%-87.90%-54.92%

Fundamentals

EPS

SNDX:

-$4.95

CIFR:

-$2.18

PS Ratio

SNDX:

7.81

CIFR:

18.93

Total Revenue (TTM)

SNDX:

$172.35M

CIFR:

$256.76M

Gross Profit (TTM)

SNDX:

$165.38M

CIFR:

$101.17M

EBITDA (TTM)

SNDX:

-$273.08M

CIFR:

-$572.32M

Returns By Period

In the year-to-date period, SNDX achieves a 11.19% return, which is significantly higher than CIFR's -12.80% return.


SNDX

1D
3.91%
1M
7.60%
YTD
11.19%
6M
51.84%
1Y
90.15%
3Y*
3.42%
5Y*
-0.35%
10Y*
5.95%

CIFR

1D
7.12%
1M
-17.50%
YTD
-12.80%
6M
2.22%
1Y
459.57%
3Y*
76.77%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SNDX vs. CIFR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNDX
SNDX Risk / Return Rank: 7878
Overall Rank
SNDX Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
SNDX Sortino Ratio Rank: 7979
Sortino Ratio Rank
SNDX Omega Ratio Rank: 7777
Omega Ratio Rank
SNDX Calmar Ratio Rank: 7777
Calmar Ratio Rank
SNDX Martin Ratio Rank: 7575
Martin Ratio Rank

CIFR
CIFR Risk / Return Rank: 9696
Overall Rank
CIFR Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
CIFR Sortino Ratio Rank: 9696
Sortino Ratio Rank
CIFR Omega Ratio Rank: 9292
Omega Ratio Rank
CIFR Calmar Ratio Rank: 9898
Calmar Ratio Rank
CIFR Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNDX vs. CIFR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Syndax Pharmaceuticals, Inc. (SNDX) and Cipher Mining Inc. (CIFR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SNDXCIFRDifference

Sharpe ratio

Return per unit of total volatility

1.35

4.18

-2.83

Sortino ratio

Return per unit of downside risk

2.08

3.60

-1.52

Omega ratio

Gain probability vs. loss probability

1.26

1.42

-0.15

Calmar ratio

Return relative to maximum drawdown

2.02

8.85

-6.83

Martin ratio

Return relative to average drawdown

4.70

19.27

-14.57

SNDX vs. CIFR - Sharpe Ratio Comparison

The current SNDX Sharpe Ratio is 1.35, which is lower than the CIFR Sharpe Ratio of 4.18. The chart below compares the historical Sharpe Ratios of SNDX and CIFR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SNDXCIFRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.35

4.18

-2.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.08

Sharpe Ratio (All Time)

Calculated using the full available price history

0.10

0.04

+0.05

Correlation

The correlation between SNDX and CIFR is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SNDX vs. CIFR - Dividend Comparison

Neither SNDX nor CIFR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SNDX vs. CIFR - Drawdown Comparison

The maximum SNDX drawdown since its inception was -78.98%, smaller than the maximum CIFR drawdown of -97.16%. Use the drawdown chart below to compare losses from any high point for SNDX and CIFR.


Loading graphics...

Drawdown Indicators


SNDXCIFRDifference

Max Drawdown

Largest peak-to-trough decline

-78.98%

-97.16%

+18.18%

Max Drawdown (1Y)

Largest decline over 1 year

-38.30%

-51.38%

+13.08%

Max Drawdown (5Y)

Largest decline over 5 years

-69.88%

Max Drawdown (10Y)

Largest decline over 10 years

-78.98%

Current Drawdown

Current decline from peak

-19.39%

-47.92%

+28.53%

Average Drawdown

Average peak-to-trough decline

-35.98%

-68.33%

+32.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.44%

23.60%

-7.16%

Volatility

SNDX vs. CIFR - Volatility Comparison

The current volatility for Syndax Pharmaceuticals, Inc. (SNDX) is 13.08%, while Cipher Mining Inc. (CIFR) has a volatility of 29.07%. This indicates that SNDX experiences smaller price fluctuations and is considered to be less risky than CIFR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SNDXCIFRDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.08%

29.07%

-15.99%

Volatility (6M)

Calculated over the trailing 6-month period

38.02%

79.48%

-41.46%

Volatility (1Y)

Calculated over the trailing 1-year period

67.33%

110.87%

-43.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.13%

122.79%

-65.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.36%

122.79%

-51.43%

Financials

SNDX vs. CIFR - Financials Comparison

This section allows you to compare key financial metrics between Syndax Pharmaceuticals, Inc. and Cipher Mining Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
68.48M
92.52M
(SNDX) Total Revenue
(CIFR) Total Revenue
Values in USD except per share items